| The broad ‘life science' division has been | | | | analysis is 2007-2015. The region wise distribution |
| witnessing a rapid growth and technological | | | | of the market consists of North America (USA |
| improvements varying from sector to sector | | | | and Canada), Europe (France, Germany, United |
| since the past 3-5 years. Accelerating growth rate | | | | Kingdom, Italy, Spain and Rest of Europe), Asia |
| exhibited by the PCR industry, even during the | | | | Pacific (Japan, China, India, Korea and Rest of |
| recession years, confirms the positive growth | | | | Asia-Pacific), Latin America (Brazil, Columbia, |
| prospects going ahead. Among the major | | | | Argentina and Rest of Latin America) and Rest of |
| developments in the recent years, gene | | | | the World. Incorporating the recession impacts on |
| amplification technology indicates the highest | | | | the industry, the market growth rate in the |
| potential growth. Molecular diagnostics and the | | | | major economies such as the U.S., Japan, China |
| Human Genome Project (HGP) are two of the | | | | etc. are estimated individually for the upcoming |
| main drivers that contribute to the growth of | | | | years. |
| gene amplification technology. It covers all | | | | Estimates are based on online surveys using |
| segments such as drug discovery, DNA | | | | customized questionnaires by our research team. |
| amplification, forensic identification, gene therapy | | | | Besides information from government databases, |
| and diagnosis. Freshly developed PCR Instruments | | | | company websites, press releases & |
| for detecting most of the life threatening diseases | | | | published research reports are also used for |
| also signal positive demand growth. | | | | estimates. Estimates have incorporated |
| The report primarily focuses on Emerging market | | | | recessionary impact on the PCR industry. |
| trends, Advancements in the technological space, | | | | Anticipated of protracted economic recovery |
| Market demand of the segments (by-region), Key | | | | towards to 2011, we have used CAGR to |
| growth areas and market size, Key competitor's | | | | forecasts to 2011 till 2015. |
| Edge. | | | | Global Market Watch: |
| The analysis primarily deals with three major | | | | The global PCR market is projected to reach |
| market segments i.e., research, diagnosis and | | | | around US$38.1 billion by 2015, with a |
| instruments. Further, the subdivided categories | | | | Compounded Annual Growth Rate (CAGR) of |
| include: | | | | 11.6% for the analysis period, 2007-2015. North |
| Research: | | | | America is estimated as the largest market with |
| - DNA Sequencing | | | | a market share of 40% of global market and |
| - Forensic Science | | | | projects US$8.5 billion by end-2010. Europe and |
| - DNA Cloning | | | | Asia-Pacific together account for approximately |
| - Others | | | | 55% of the global market share. Interestingly, |
| Diagnosis: | | | | Latin America is seen as the fastest growing |
| - Infectious Diseases | | | | market with a CAGR of 15.3%, to worth around |
| - Cancer | | | | US$0.8 billion in 2015. Irrespective of the economic |
| - Genetic Abnormalities | | | | turmoil, Japan is expected to hold the second rank |
| Instruments: | | | | among the countries holding top-PCR market |
| - Instrumentation | | | | share, figured to occupy 13% of the global |
| - Reagents | | | | market in 2012 with a market value of US$3.3 |
| - Consumables | | | | billion. |
| The period considered for the PCR market | | | | |